Humacyte (HUMA)

Humacyte (HUMA) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• HUMA last traded at $0.41, -12.47% on the day.
• Humacyte: P/E -0.8, revenue $2.12M over the last four quarters.
• Over the past year HUMA returned -74.62%; year to date -57.19%.

Updated 2026-11-03 02:47 UTC